HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by van den Berg, R. J Articles by Kuijper, E. J Search for Related Content PubMed PubMed Citation Articles by van den Berg, R. J Articles by Kuijper, E. J Agricola Articles by van den Berg, R. J Articles by Kuijper, E. J

Coexistence of multiple PCR-ribotype strains of Clostridium difficile in faecal samples limits epidemiological studies

¹Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Centre, Leiden, The Netherlands ²Department of Medical Microbiology, VU University Medical Centre, Amsterdam, The Netherlands

Correspondence Ed J. Kuijper e.j.kuijper{at}lumc.nl

Received July 16, 2004
Accepted October 21, 2004

Clostridium difficile is an important cause of antibiotic-associated diarrhoea. The simultaneous presence of different strains in individual faecal samples has not yet been established, but is important for epidemiological studies. Recurrences of Clostridium difficile-associated diarrhoea (CDAD) are observed in 15–20 % of patients and have been reported as relapses or reinfections with a new strain. In a period of 1 year, 28 faecal samples from 23 patients with a first episode of CDAD were collected at the Leiden University Medical Centre. In addition, 52 faecal samples from 23 patients, from three different hospitals, with one (n = 19), two (n = 2) or three (n = 2) recurrences were studied. PCR-ribotyping was applied as the standard typing method for the isolates. The toxinogenic and clindamycin-resistance profiles of the isolates was determined by PCR. Of 23 patients with a first episode of CDAD, two (8.7 %) harboured two different types, with no differences in toxinogenicity or clindamycin resistance, within one faecal sample. One of these 23 patients showed two types in three faecal samples from the same episode. Of the 23 patients with recurrences, six (26 %) showed a different strain type isolated in a recurrent episode. The number of cases of multiple C. difficile strains in faecal samples from patients with a first episode of CDAD did not differ significantly from the number of different strains present in recurrent episodes (chi-square test, P 0.2). This observation limits the application of typing methods for studying the epidemiology of CDAD.

Abbreviations: CDAD, Clostridium difficile-associated diarrhoea; REA, restriction enzyme analysis.

This article has been cited by other articles:

				D. Wroblewski, G. E. Hannett, D. J. Bopp, G. K. Dumyati, T. A. Halse, N. B. Dumas, and K. A. Musser Rapid Molecular Characterization of Clostridium difficile and Assessment of Populations of C. difficile in Stool Specimens J. Clin. Microbiol., July 1, 2009; 47(7): 2142 - 2148. [Abstract] [Full Text] [PDF]

				P. D. Stamper, R. Alcabasa, D. Aird, W. Babiker, J. Wehrlin, I. Ikpeama, and K. C. Carroll Comparison of a Commercial Real-Time PCR Assay for tcdB Detection to a Cell Culture Cytotoxicity Assay and Toxigenic Culture for Direct Detection of Toxin-Producing Clostridium difficile in Clinical Samples J. Clin. Microbiol., February 1, 2009; 47(2): 373 - 378. [Abstract] [Full Text] [PDF]

				P. L. Hinkson, C. Dinardo, D. DeCiero, J. D. Klinger, and R. H. Barker Jr. Tolevamer, an Anionic Polymer, Neutralizes Toxins Produced by the BI/027 Strains of Clostridium difficile Antimicrob. Agents Chemother., June 1, 2008; 52(6): 2190 - 2195. [Abstract] [Full Text] [PDF]

				A. Indra, D. Schmid, S. Huhulescu, M. Hell, R. Gattringer, P. Hasenberger, A. Fiedler, G. Wewalka, and F. Allerberger Characterization of clinical Clostridium difficile isolates by PCR ribotyping and detection of toxin genes in Austria, 2006-2007 J. Med. Microbiol., June 1, 2008; 57(6): 702 - 708. [Abstract] [Full Text] [PDF]

				R. J. van den Berg, N. Vaessen, H. P. Endtz, T. Schulin, E. R. van der Vorm, and E. J. Kuijper Evaluation of real-time PCR and conventional diagnostic methods for the detection of Clostridium difficile-associated diarrhoea in a prospective multicentre study J. Med. Microbiol., January 1, 2007; 56(1): 36 - 42. [Abstract] [Full Text] [PDF]

				N. Sadeghifard, V. Gurtler, M. Beer, and R. J. Seviour The Mosaic Nature of Intergenic 16S-23S rRNA Spacer Regions Suggests rRNA Operon Copy Number Variation in Clostridium difficile Strains Appl. Envir. Microbiol., November 1, 2006; 72(11): 7311 - 7323. [Abstract] [Full Text] [PDF]

				T. Noren, M. Wullt, T. Akerlund, E. Back, I. Odenholt, and L. G. Burman Frequent Emergence of Resistance in Clostridium difficile during Treatment of C. difficile-Associated Diarrhea with Fusidic Acid. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3028 - 3032. [Abstract] [Full Text] [PDF]

				R. J. van den Berg, L. S. Bruijnesteijn van Coppenraet, H.-J. Gerritsen, H. P. Endtz, E. R. van der Vorm, and E. J. Kuijper Prospective Multicenter Evaluation of a New Immunoassay and Real-Time PCR for Rapid Diagnosis of Clostridium difficile-Associated Diarrhea in Hospitalized Patients J. Clin. Microbiol., October 1, 2005; 43(10): 5338 - 5340. [Abstract] [Full Text] [PDF]

				I. R Poxton Clostridium difficile J. Med. Microbiol., February 1, 2005; 54(2): 97 - 100. [Full Text] [PDF]